Erste Asset Management Gmb H Bridge Bio Pharma, Inc. Transaction History

Erste Asset Management Gmb H

$11.9 Trillion
Q2 2025

A detailed history of Erste Asset Management Gmb H transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 140,225 shares of BBIO stock, worth $7.75 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

140,225

Previous 140,225 -0.0%

Holding current value

$7.75 Million

Previous $4.92 Billion 27.77%

% of portfolio

0.05%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $3.35 Million - $4.39 Million	140,225 New	140,225 $3.5 Billion
Q2 2024 Nov 26, 2024	BUY	$23.0 - $31.04 $759,000 - $1.02 Million	33,000 Added 30.78%	140,225 $3.53 Billion
Q1 2024 Nov 26, 2024	BUY	$27.35 - $40.45 $629,050 - $930,350	23,000 Added 27.31%	107,225 $3.31 Billion
Q4 2023 Nov 26, 2024	BUY	$24.02 - $43.89 $384,320 - $702,240	16,000 Added 23.45%	84,225 $3.52 Billion
Q3 2023 Nov 26, 2024	BUY	$16.89 - $35.01 $506,700 - $1.05 Million	30,000 Added 78.48%	68,225 $1.85 Billion
Q1 2023 Nov 26, 2024	BUY	$7.17 - $18.55 $215,100 - $556,500	30,000 Added 78.48%	68,225 $1.17 Billion
Q3 2022 Nov 26, 2024	SELL	$7.94 - $12.36 $809,880 - $1.26 Million	-102,000 Reduced 72.74%	38,225 $390 Million
Q2 2022 Nov 26, 2024	SELL	$5.21 - $12.14 $531,420 - $1.24 Million	-102,000 Reduced 72.74%	38,225 $338 Million
Q1 2022 Nov 22, 2024	SELL	$7.34 - $17.16 $139,460 - $326,040	-19,000 Reduced 33.2%	38,225 $396 Million
Q4 2021 Nov 22, 2024	SELL	$11.38 - $53.41 $944,540 - $4.43 Million	-83,000 Reduced 59.19%	57,225 $812 Million
Q3 2021 Nov 22, 2024	SELL	$46.87 - $64.24 $899,904 - $1.23 Million	-19,200 Reduced 25.12%	57,225 $2.73 Billion
Q1 2021 Nov 22, 2024	BUY	$55.47 - $72.35 $1.08 Million - $1.41 Million	19,425 Added 34.08%	76,425 $4.52 Billion
Q3 2020 Nov 22, 2024	SELL	$27.2 - $42.19 $2.26 Million - $3.51 Million	-83,225 Reduced 59.35%	57,000 $2.11 Billion
Q4 2019 Nov 22, 2024	SELL	$17.96 - $46.63 $1.49 Million - $3.88 Million	-83,225 Reduced 59.35%	57,000 $2.1 Billion
Q3 2019 Nov 22, 2024	SELL	$20.13 - $32.38 $2.36 Million - $3.8 Million	-117,225 Reduced 83.6%	23,000 $463 Million

Others Institutions Holding BBIO

# of Institutions

409

Shares Held

187M

Call Options Held

11.3M

Put Options Held

2.2M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $8.2B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Bridge Bio Pharma, Inc. Transaction History